Noninfectious Complications of Blood Transfusion

2007 ◽  
Vol 131 (5) ◽  
pp. 708-718 ◽  
Author(s):  
Anne F. Eder ◽  
Linda A. Chambers

Abstract Context.—Serious noninfectious complications are far more likely to occur than viral disease transmission from blood component transfusion. Objective.—To compile a comprehensive list of the noninfectious risks of transfusion, examples of published risk estimates, and summaries of recent information regarding cause, prevention, or management of noninfectious transfusion risks. Data Sources.—Information was obtained from peer-reviewed English-language medical journal publications since 1990. Conclusions.—Early complications, although potentially more serious, usually occur less frequently (<1 in 1000 transfusions) than late complications, which often affect more than 1% of recipients. Areas of active investigation and discussion include acute hemolytic reactions, transfusion-related acute lung injury, red cell alloimmunization, platelet transfusion refractoriness, and transfusion immunosuppression. Continued effort toward research and education to promote recognition and prevention of noninfectious complications associated with blood components is warranted.

1995 ◽  
Vol 81 (2) ◽  
pp. 272-278
Author(s):  
Douglas G. Clayton ◽  
Adelaida M. Miro ◽  
David J. Kramer ◽  
Nathaniel Rodman ◽  
Stanley Wearden

Surgery ◽  
2014 ◽  
Vol 156 (3) ◽  
pp. 564-569 ◽  
Author(s):  
Hunter B. Moore ◽  
Ernest E. Moore ◽  
Theresa L. Chin ◽  
Eduardo Gonzalez ◽  
Michael P. Chapman ◽  
...  

1983 ◽  
Vol 11 (4) ◽  
pp. 361-368 ◽  
Author(s):  
Anthony Dodds ◽  
Maryann Nicholls

Renal diseases are associated with a variety of haemopoietic changes. Anaemia parallels the degree of renal impairment and its most important cause is failure of renal erythropoietin secretion. Other factors include depressed red cell production and reduced red cell survival. Purpura and bleeding are predominantly due to platelet dysfunction and usually respond to dialysis. Cryoprecipitate and 1-deamino-8-d-arginine vasopressin may be of value in the bleeding patient. Abnormal coagulation with fibrin deposition in the microcirculation is now recognised as a mechanism of renal impairment. Plasma infusion and anticoagulants may be useful in the therapy of conditions in which this occurs. Plasma exchange is now used in the investigation and management of some varieties of immunologically mediated renal disease. Blood transfusion has been found to improve graft survival if given prior to renal transplantation and this effect is currently under active investigation.


1989 ◽  
Vol 15 (11) ◽  
pp. 347-353
Author(s):  
Mercy Kuriyan ◽  
Dae Un Kim ◽  
Richard Harveston

Sign in / Sign up

Export Citation Format

Share Document